VISCOWIN-IL INHALER
MRP: 396
Packaging: 200 MD
Pack Type: inhaler
Composition:
Ipratropium Bromide 20mg + Levosalbutamol 50mg
Indication:
Asthma, COPD, Chronic bronchitis, Emphysema
Description:
This inhalation solution contains a dual bronchodilator combination:
Levosalbutamol (50 mcg): A selective β2-agonist that provides rapid bronchodilation and relief of acute bronchospasm.
Ipratropium Bromide (20 mcg): An anticholinergic agent that inhibits bronchoconstriction mediated by vagal stimulation.
Together, they offer complementary mechanisms of action to relax airway smooth muscles, improve airflow, and control symptoms in asthma, COPD, and chronic bronchitis. Ideal for moderate to severe airway obstruction or those unresponsive to monotherapy.
Tags:
- Rapid onset of action
- Combines two bronchodilation pathways
- Effective for moderate to severe COPD
- Reduces hospital visits in chronic cases
- Isotonic and gentle on respiratory mucosa
Usage Information
Dosage
Usual adult dose: 2.5 ml solution (depending on dilution), 3–4 times daily Administer using jet nebulizer under medical supervision Do not exceed recommended frequency or dose Shake before use if in vial form
Side Effects
Dry mouth Headache Tremor Palpitations Cough or throat irritation Rare: paradoxical bronchospasm
Contraindications
Hypersensitivity to levalbuterol or ipratropium Use with caution in cardiovascular disorders, hyperthyroidism, glaucoma, or prostatic hypertrophy Avoid in patients with narrow-angle glaucoma